• Book a demo
  • Login for members
  • Contact us
  • FAQ
  • Terms and Conditions
MAP MedTech
  • Home
  • About Us
    • Who We Are
    • What We Provide
    • Where We Are
    • Get In Touch!
  • Tools
    • Online Tools Platform
    • ICER Calculator
    • Budget Impact Model
  • META
  • Insights
    • Patient Access 2020
    • Publications
    • News
    • Consultations
    • Events
  • Resources
    • Market Access Training
    • MAP Posters
    • MAP Podcasts
    • Glossary
    • Links
    • Directory
  • MAP Countries
    • MAP Europe
    • MAP United Kingdom
    • MAP Germany
    • MAP France
    • MAP Demo
  • Careers

MAP Germany

Not a member yet? - Register now

  • MAP Germany
    • Germany Country Overview
  • Table of Contents
  • Market Access Overview
  • Decision Makers
    • The Federal Joint Committee (G-BA)
    • The Institute for Quality and Efficiency in Healthcare (IQWiG)
    • The Federal Institute for Drugs and Medical Devices (BfArM)
  • Public Affairs
    • Executive and Legislative Powers
    • Lobbying
  • Product Licensing
    • Clinical Studies
  • Reimbursement
    • First Placing
    • In-Patient Reimbursement
      • The NUB Reimbursement Pathway
      • HTA Procedure for High Risk Class Medical Devices (§ 137 h SGB V)
    • Out-Patient Reimbursement
      • Assessments of Potential, Testing Regulation ( § 137 e SGB V)
  • Guidance on Medical Apps
Latest Updates
  • Market Access Overview
  • The NUB Reimbursement Pathway
  • Public Affairs
  • HTA Procedure for High Risk Class Medical Devices (§ 137 h SGB V)

1 matches for the tag »The Bundesrat«

Executive and Legislative Powers

Summary Germany is comprised of sixteen states (also referred to as Länder or Laender) and is a federal, democratic republic. … read more »

URL https://mapmedtech.com/germany/public-affairs-in-germany/executive-and-legislative-powers-in-germany/


Tag Cloud

Authorised Representative BfArM CE Mark Classification Clinical Studies Code of Conduct Competent Authority Diagnostic DIMDI Ethics Europe Executive Federal Law First Placing G-BA Germany Government Government Affairs InEK In Patient In vitro IQWiG Law Legislative Lobbying Manufacturer Market Medical Apps MPG NUB Out Patient PKV Private Health Insurance Public Affairs Public Relations Register Reimbursement Risk Serious Adverse Events Software The Bundesrat The Bundestag The Federal Institute for Drugs and Medical Devices The Federal Joint Committee The Institute for Quality and Efficiency in Healthcare

MAP Germany - Table of Contents

  • MAP Germany
    • Germany Country Overview
  • Table of Contents
  • Market Access Overview
  • Decision Makers
    • The Federal Joint Committee (G-BA)
    • The Institute for Quality and Efficiency in Healthcare (IQWiG)
    • The Federal Institute for Drugs and Medical Devices (BfArM)
  • Public Affairs
    • Executive and Legislative Powers
    • Lobbying
  • Product Licensing
    • Clinical Studies
  • Reimbursement
    • First Placing
    • In-Patient Reimbursement
      • The NUB Reimbursement Pathway
      • HTA Procedure for High Risk Class Medical Devices (§ 137 h SGB V)
    • Out-Patient Reimbursement
      • Assessments of Potential, Testing Regulation ( § 137 e SGB V)
  • Guidance on Medical Apps

More Information

  • About us
  • Frequently Asked Questions
  • Service Details
  • Registration Form
  • Consulting
  • Take a Tour
  • Terms & Conditions

Our Office

MAP MedTech Limited
Upper Pendrill Court
Ermine Street North
Papworth Everard
Cambridge
CB23 3UY
United Kingdom

MAP MedTech Limited No: 08635724

Contact us

Phone: +44 1480 832360
Email: enquiries@mapmedtech.com

or use the Contact Form

Please also visit our partner site:

MAP BioPharma

Top of Page

MAP MedTech Limited © 2012-2021. All rights reserved | Imprint & Disclaimer | Data Privacy

Site designed and developed by 72dpi. 88 queries. 0.831 seconds.

MAP MedTech Login

I lost my password

Not a subscriber yet? See our Q&A's and subscription details.